vs
Profound Medical Corp.(PROF)与TECHPRECISION CORP(TPCS)财务数据对比。点击上方公司名可切换其他公司
TECHPRECISION CORP的季度营收约是Profound Medical Corp.的1.2倍($7.1M vs $6.0M),TECHPRECISION CORP净利率更高(-20.8% vs -136.8%,领先116.0%)
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业,专注于为医疗领域开发并提供相关软件产品,面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年,该公司全球员工规模超9200人,业务覆盖56个国家,拥有超过160万用户。
TechPrecision Corp是一家专业生产定制高精度金属部件与集成系统的制造商,服务航空航天、国防、医疗科技、可再生能源等核心领域,为欧美客户提供符合严苛行业标准的关键任务零部件。
PROF vs TPCS — 直观对比
营收规模更大
TPCS
是对方的1.2倍
$6.0M
净利率更高
TPCS
高出116.0%
-136.8%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $6.0M | $7.1M |
| 净利润 | $-8.2M | $-1.5M |
| 毛利率 | 66.8% | 5.4% |
| 营业利润率 | -123.3% | -19.1% |
| 净利率 | -136.8% | -20.8% |
| 营收同比 | — | -6.9% |
| 净利润同比 | — | -84.4% |
| 每股收益(稀释后) | $0.27 | $-0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PROF
TPCS
| Q4 25 | $6.0M | $7.1M | ||
| Q3 25 | $5.1M | $9.1M | ||
| Q2 25 | $2.0M | $7.4M | ||
| Q1 25 | $2.3M | $9.5M | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | — | $8.9M | ||
| Q2 24 | — | $8.0M | ||
| Q1 24 | — | $8.6M |
净利润
PROF
TPCS
| Q4 25 | $-8.2M | $-1.5M | ||
| Q3 25 | $-8.0M | $825.0K | ||
| Q2 25 | $-15.7M | $-597.0K | ||
| Q1 25 | $-10.7M | $112.0K | ||
| Q4 24 | — | $-799.0K | ||
| Q3 24 | — | $-601.0K | ||
| Q2 24 | — | $-1.5M | ||
| Q1 24 | — | $-5.1M |
毛利率
PROF
TPCS
| Q4 25 | 66.8% | 5.4% | ||
| Q3 25 | 77.7% | 27.1% | ||
| Q2 25 | 81.7% | 14.0% | ||
| Q1 25 | 79.2% | 22.0% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | — | 11.3% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 14.3% |
营业利润率
PROF
TPCS
| Q4 25 | -123.3% | -19.1% | ||
| Q3 25 | -176.2% | 10.4% | ||
| Q2 25 | -696.9% | -6.3% | ||
| Q1 25 | -477.0% | 3.9% | ||
| Q4 24 | — | -9.1% | ||
| Q3 24 | — | -5.5% | ||
| Q2 24 | — | -16.8% | ||
| Q1 24 | — | -28.6% |
净利率
PROF
TPCS
| Q4 25 | -136.8% | -20.8% | ||
| Q3 25 | -157.7% | 9.1% | ||
| Q2 25 | -792.3% | -8.1% | ||
| Q1 25 | -458.1% | 1.2% | ||
| Q4 24 | — | -10.5% | ||
| Q3 24 | — | -6.7% | ||
| Q2 24 | — | -18.3% | ||
| Q1 24 | — | -59.5% |
每股收益(稀释后)
PROF
TPCS
| Q4 25 | $0.27 | $-0.15 | ||
| Q3 25 | $0.26 | $0.08 | ||
| Q2 25 | $0.52 | $-0.06 | ||
| Q1 25 | $0.36 | $0.01 | ||
| Q4 24 | — | $-0.08 | ||
| Q3 24 | — | $-0.06 | ||
| Q2 24 | — | $-0.16 | ||
| Q1 24 | — | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $59.7M | $50.0K |
| 总债务越低越好 | $4.5M | — |
| 股东权益账面价值 | $66.4M | $8.0M |
| 总资产 | $77.5M | $32.8M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势,按日历期对齐
现金及短期投资
PROF
TPCS
| Q4 25 | $59.7M | $50.0K | ||
| Q3 25 | $24.8M | $220.0K | ||
| Q2 25 | $35.2M | $143.0K | ||
| Q1 25 | $46.4M | $195.0K | ||
| Q4 24 | — | $165.0K | ||
| Q3 24 | — | $132.0K | ||
| Q2 24 | — | $44.8K | ||
| Q1 24 | — | $138.0K |
总债务
PROF
TPCS
| Q4 25 | $4.5M | — | ||
| Q3 25 | $4.5M | — | ||
| Q2 25 | $4.5M | — | ||
| Q1 25 | $4.5M | $3.0K | ||
| Q4 24 | — | $19.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
PROF
TPCS
| Q4 25 | $66.4M | $8.0M | ||
| Q3 25 | $32.1M | $9.1M | ||
| Q2 25 | $39.3M | $8.2M | ||
| Q1 25 | $50.8M | $8.7M | ||
| Q4 24 | — | $8.1M | ||
| Q3 24 | — | $8.9M | ||
| Q2 24 | — | $7.9M | ||
| Q1 24 | — | $7.8M |
总资产
PROF
TPCS
| Q4 25 | $77.5M | $32.8M | ||
| Q3 25 | $42.3M | $33.8M | ||
| Q2 25 | $49.7M | $32.1M | ||
| Q1 25 | $60.9M | $33.5M | ||
| Q4 24 | — | $32.2M | ||
| Q3 24 | — | $35.0M | ||
| Q2 24 | — | $35.7M | ||
| Q1 24 | — | $34.7M |
负债/权益比
PROF
TPCS
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.09× | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-6.6M | $183.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-827.0K |
| 自由现金流率自由现金流/营收 | — | -11.7% |
| 资本支出强度资本支出/营收 | — | 14.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-4.4M |
8季度趋势,按日历期对齐
经营现金流
PROF
TPCS
| Q4 25 | $-6.6M | $183.0K | ||
| Q3 25 | $-9.6M | $-1.1M | ||
| Q2 25 | $-13.7M | $646.0K | ||
| Q1 25 | $-8.3M | $396.0K | ||
| Q4 24 | — | $-570.0K | ||
| Q3 24 | — | $-532.0K | ||
| Q2 24 | — | $107.0K | ||
| Q1 24 | — | $-452.0K |
自由现金流
PROF
TPCS
| Q4 25 | — | $-827.0K | ||
| Q3 25 | — | $-2.1M | ||
| Q2 25 | — | $-604.0K | ||
| Q1 25 | — | $-930.0K | ||
| Q4 24 | — | $-1.7M | ||
| Q3 24 | — | $-2.0M | ||
| Q2 24 | — | $-94.0K | ||
| Q1 24 | — | $-900.0K |
自由现金流率
PROF
TPCS
| Q4 25 | — | -11.7% | ||
| Q3 25 | — | -22.9% | ||
| Q2 25 | — | -8.2% | ||
| Q1 25 | — | -9.8% | ||
| Q4 24 | — | -22.9% | ||
| Q3 24 | — | -21.8% | ||
| Q2 24 | — | -1.2% | ||
| Q1 24 | — | -10.5% |
资本支出强度
PROF
TPCS
| Q4 25 | — | 14.2% | ||
| Q3 25 | — | 11.0% | ||
| Q2 25 | — | 16.9% | ||
| Q1 25 | — | 14.0% | ||
| Q4 24 | — | 15.4% | ||
| Q3 24 | — | 15.9% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | — | 5.2% |
现金转化率
PROF
TPCS
| Q4 25 | — | — | ||
| Q3 25 | — | -1.31× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.54× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PROF
暂无分部数据
TPCS
| Defense | $6.7M | 94% |
| Other | $410.0K | 6% |